A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

NCT05549505 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: ARV-471
DRUG: Anastrozole
PROCEDURE: Surgical resection of breast tumor

Sponsor

Arvinas Inc.

Collaborators

[object Object]